?Antazoline Hydrochloride (CAS 2508-72-7)?
? ?Product Overview?
Antazoline Hydrochloride (C??H??ClN?, MW: 301.81) is a first-generation antihistamine and anticholinergic agent, widely recognized for its dual action in treating allergic reactions and cardiac arrhythmias. As a white crystalline powder, it exhibits high solubility in ethanol and limited solubility in water or ether?12. Primarily used in pharmaceuticals and research, it addresses conditions like allergic rhinitis, conjunctivitis, and ventricular arrhythmias?15.

? ?Key Advantages?
?? ?High Purity?: ≥99% (HPLC-verified), ensuring pharmaceutical-grade quality?14.
?? ?Thermal Stability?: Melting point ?238°C?, suitable for long-term storage at ?2–8°C??24.
?? ?Multi-Functionality?: Combines antihistamine, anticholinergic, and local anesthetic effects?15.
?? ?Regulatory Compliance?: Meets ?USP42? standards for global pharmaceutical applications?23.

? ?Applications?

1. ?Human Medicine?: Management of allergic reactions, arrhythmias, and preoperative sedation?.

2. ?Ophthalmic Solutions?: Topical treatment for allergic conjunctivitis?.

3. ?Research?: Study of histamine receptor mechanisms and drug development?.

? ?Quality Assurance?
Tested via ?HPLC?, ?FTIR?, and ?mass spectrometry?, with batch-specific Certificates of Analysis (COAs). Stability validated per ?ICH guidelines? and solubility confirmed in ethanol (≥20 mg/mL)?14.

? ?Market Insights?
The global antihistamine market is projected to grow at ?5.2% CAGR (2025–2030)?, driven by rising allergy prevalence and demand for multifunctional therapeutic agents?6.